Sun Biopharma, Inc. (SNBP) Starts Presentation at the 2017 Marcum Microcap Conference
Sun Biopharma (OTC: SNBP) is a clinical-stage biopharmaceutical company developing therapeutics for urgent unmet medical needs. The company’s development programs target diseases of the pancreas and its initial product candidate is SBP-101 for the treatment of patients with pancreatic cancer. Sun BioPharma has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, the University of Miami, the University of Florida, the Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre in Melbourne, Australia and the Ashford Cancer Centre in Adelaide, Australia. For more information, visit the company's website at www.sunbiopharma.com About NetworkNewsWire NetworkNewsWire (NNW) is…